1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow CerRx, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas Fenretinide - Peripheral T-cell Lymphoma | Phase 2 | Unknown | CerRx, Inc. | 140 | 2016-12-01 | 2019-07-23 |
Lymphoma, T-Cell, Peripheral (1)
Fenretinide (1)
United States (1)